Christopher Taylor active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - |
Career history of Christopher Taylor
Former positions of Christopher Taylor
| Companies | Position | Start | End |
|---|---|---|---|
| CODIAK BIOSCIENCES | Investor Relations Contact | 2020-11-30 | 2023-05-31 |
| Public Communications Contact | 2020-11-30 | 2023-05-31 | |
| ALAUNOS THERAPEUTICS, INC. | Investor Relations Contact | 2019-02-28 | - |
| Public Communications Contact | 2019-02-28 | - |
Statistics
International
| United States | 4 |
Operational
| Investor Relations Contact | 3 |
| Public Communications Contact | 3 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Christopher Taylor
- Experience
